1. A peptide mimic blocks the cross‐reaction of anti‐DNA antibodies with glomerular antigens. (8th December 2015) Authors: Xia, Y.; Eryilmaz, E.; Der, E.; Pawar, R. D.; Guo, X.; Cowburn, D.; Putterman, C. Journal: Clinical and experimental immunology Issue: Volume 183:Number 3(2016:Mar.) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0435 Immunosignature Technology Identifies Systemic Lupus Erythematosus from A Drop of Serum. (15th July 2016) Authors: Nayak, B.P.; Putterman, C.; Gerwien, R.; Sykes, K.; Tarasow, T.M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. B7x/B7‐H4 modulates the adaptive immune response and ameliorates renal injury in antibody‐mediated nephritis. (February 2015) Authors: Pawar, R. D.; Goilav, B.; Xia, Y.; Herlitz, L.; Doerner, J.; Chalmers, S.; Ghosh, K.; Zang, X.; Putterman, C. Journal: Clinical and experimental immunology Issue: Volume 179:Number 2(2015:Feb.) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benign recurrent intrahepatic cholestasis--25 years of follow-up. Issue 738 (April 1987) Authors: Putterman, C.; Keidar, S.; Brook, J. G. Journal: Postgraduate medical journal Issue: Volume 63:Issue 738(1987) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0043 RENAL TUBULAR COMPLEMENT C9 DEPOSITION IS ASSOCIATED WITH RENAL TUBULAR DAMAGE AND FIBROSIS IN LUPUS NEPHRITIS. (2nd June 2020) Authors: Wang, S.; Wu, M.; Chiriboga, L.; Putterman, C.; Goilav, B.; Broder, A. R.; Belmont, H. M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0164 Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase. (15th July 2016) Authors: Chalmers, S.A.; Doerner, J.; Bosanac, T.; Khalil, S.; Smith, D.; Harcken, C.; Dimock, J.; Der, E.; Herlitz, L.; Webb, D.; Seccareccia, E.; Feng, D.; Fine, J.S.; Ramanujam, M.; Klein, E.; Putterman, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0217 A permeable blood-brain barrier is not required for neuropsychatric manifestations in sle and pss. (12th June 2018) Authors: Lauvsnes, M.B.; Tjensvoll, A.B.; Maroni, S.S.; Kvivik, I.; Grimstad, T.B.; Greve, O.J.; Harboe, E.; Gøransson, L.G.; Putterman, C.; Omdal, R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0590 SLE-Keytm Rule-Out Serlogic Test for SLE Using the Immunarray ICHIP™. (9th June 2015) Authors: Cohen, I.; Putterman, C.; Jordan, N.; Jakobi, K.; Sorek, R.; Blumenstein, Y.; Batty, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0317 Tubuloinsterstial Damage Is An Independent Predictor of End Stage Renal Disease in Lupus Nephritis Patients with Mild To Moderate Renal Impairment. (15th July 2016) Authors: Jovanovic, B.; Khan, H.N.; Mowrey, W.; Izmirly, P.; Schwartz, D.; Buyon, J.; Putterman, C.; Goilav, B.; Broder, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗